Related Experiment Videos

Communicating the value of adjuvant chemotherapy

Guru Sonpavde¹

¹Division of Hematology-Oncology, Department of Internal Medicine, Maricopa County Medical Center, Phoenix, AZ, USA. gsonpavde@att.net

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|March 1, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Addition of immune checkpoint inhibitors to intravesical BCG for high-risk BCG-naïve non-muscle invasive bladder cancer: Systematic review and meta-analysis.

BJUI compass·2026

Radiation and Avelumab in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer.

Clinical genitourinary cancer·2026

Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial.

Nature medicine·2026

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

CA: a cancer journal for clinicians·2025

Toward a better pan-tumor predictive signature for unleashing precision immuno-oncology.

Journal for immunotherapy of cancer·2025

Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV Administration.

Journal of immunotherapy and precision oncology·2025

See all related articles